3 Boomerang Capital Forms LSOMS Holdings, L.P., a Quality & Regulatory Consulting Platform Led by Life Sciences Veteran John Duffin

GREENWICH, Conn. and FISHERS, Ind., June 3, 2025 /PRNewswire/ -- 3 Boomerang Capital, LP ("3BC"), a healthcare-focused, lower-middle-market private equity firm, today announced the launch of LSOMS Holdings, L.P. ("LSOMS", "LSOMS Holdings" or the "Company"), a specialty consulting platform dedicated to assisting life science and medical device companies in managing quality assurance, operational excellence, regulatory compliance, and other critical activities within manufacturing and laboratory environments. 3BC is partnering in this venture with John Duffin, an industry veteran with more than two decades of experience acquiring, integrating, and scaling life sciences, manufacturing and consulting businesses.

"We came together to bring deep experience and an intensely acute focus on quality compliance and operational excellence to our clients. Additionally, we will be a strategic partner to life sciences companies, empowering them to enhance their capabilities at every step in the lifecycle," said John Duffin, Chief Executive Officer. "Our extensive industry expertise and track record of agile execution can help these companies accelerate the delivery of their life-changing therapies while remaining in compliance and operating efficiently."

Peter Wen, Principal at 3 Boomerang Capital, added, "We're thrilled to partner with John, whose impressive track record and values-driven leadership perfectly align with our vision. Together, we are committed to intentional growth by investing in exceptional talent and innovative technology. The Company will consistently evolve its capabilities, ensuring we remain a trusted, world-class partner for critical quality and compliance solutions that drive client success."

Jay Marshall, Parter, Managing Director and Chief Learning Partner at AlixPartners, will serve as Chairman of the Board of Directors. Marshall brings over 30 years of extensive experience scaling professional services organizations, notably playing a key role in growing AlixPartners into a leading global consultancy. "It's an honor to join forces with 3BC and John to create a differentiated and impactful platform in the life sciences sector," said Marshall. "I look forward to contributing my expertise in scaling high-performing consulting organizations, ensuring LSOMS delivers exceptional value to our clients."

The Company's initial services will focus on validation, compliance, quality assurance (QA/QC), and regulatory strategy. The firm emphasizes building deep, collaborative client relationships and prioritizes ongoing professional development. LSOMS has made plans for strategic acquisitions and investments to expand its capabilities and reinforce its culture – attracting and retaining top-tier quality, engineering, and regulatory professionals.

About LSOMS Holdings

LSOMS Holdings provides quality, regulatory, and operational excellence consulting to biopharmaceutical, medical device, and CDMO companies worldwide. The company's mission is to deliver expert-driven, compliant solutions that empower clients to accelerate innovation and improve human health. LSOMS supports life sciences organizations by ensuring operational readiness, reducing the risk of regulatory setbacks, and enabling clients to stay focused on advancing science, supporting patients, and bringing new therapies to market. As a trusted partner, LSOMS elevates compliance and empowers innovation across the product lifecycle.

About 3 Boomerang Capital

3 Boomerang Capital is a lower-middle-market healthcare private equity firm committed to fostering creative investment partnerships with healthcare entrepreneurs across North America and Western Europe. 3BC's areas of investment focus span four key healthcare sectors: biopharma outsourcing, medical device and diagnostic manufacturing, information technology and tech-enabled services, and alternate site care. The firm specializes in backing founder-led businesses, providing the guidance and resources needed for successful growth and innovation in the healthcare market. By strategically concentrating on four core areas, 3 Boomerang Capital is well-equipped to deliver on its mission of empowering healthcare entrepreneurs and propelling healthcare businesses to new heights. The firm is currently investing out of its flagship fund, 3 Boomerang Capital I, LP, a $376 million investment vehicle.

For more information, visit https://www.3boomerang.com/

Media Contact

Alixe Kluttz
Chief of Staff
3 Boomerang Capital
[email protected] 

Laura Simpson
JConnelly for 3 Boomerang Capital
[email protected]

SOURCE 3 Boomerang Capital